{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:33:57Z","timestamp":1794857637063,"version":"4.9.1"},"reference-count":25,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,3,1]]},"abstract":"<jats:p>Angiogenesis plays an important role in the biology of multiple myeloma (MM) and has prognostic importance in this disease. Solitary plasmacytoma is a localized plasma cell malignancy that progresses to MM in a significant number of patients. We examined if angiogenesis is increased in solitary plasmacytoma and if it can help identify patients likely to progress to myeloma. We studied angiogenesis in plasmacytoma biopsy samples and bone marrow biopsies from 25 patients. High-grade angiogenesis was present in 64% of plasmacytomas. In contrast, bone marrow angiogenesis was low in all patients. Patients with high-grade angiogenesis in the plasmacytoma sample were more likely to progress to myeloma and had a shorter progression-free survival compared with patients with low-grade angiogenesis (P\u2009=\u2009.02). Angiogenesis is increased in solitary plasmacytoma and is a significant predictor of progression to myeloma and provides further evidence of its importance in the pathogenesis of myeloma.<\/jats:p>","DOI":"10.1182\/blood-2002-08-2441","type":"journal-article","created":{"date-parts":[[2003,2,12]],"date-time":"2003-02-12T14:59:36Z","timestamp":1045061976000},"page":"1715-1717","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":93,"title":["Prognostic value of angiogenesis in solitary bone plasmacytoma"],"prefix":"10.1182","volume":"101","author":[{"given":"Shaji","family":"Kumar","sequence":"first","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Fonseca","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha Q.","family":"Lacy","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Lust","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Wellik","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Witzig","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morie A.","family":"Gertz","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Kyle","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip R.","family":"Greipp","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Vincent","family":"Rajkumar","sequence":"additional","affiliation":[{"name":"From the Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111822461108000_B1","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.1992.10.4.587","article-title":"Curability of solitary bone plasmacytoma.","volume":"10","author":"Dimopoulos","year":"1992","journal-title":"J Clin Oncol."},{"key":"2019111822461108000_B2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1200\/JCO.1983.1.4.255","article-title":"Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone.","volume":"1","author":"Knowling","year":"1983","journal-title":"J Clin Oncol."},{"key":"2019111822461108000_B3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/bjc.1995.26","article-title":"Localised plasmacytomas in Taiwan: comparison between extramedullary plasmacytoma and solitary plasmacytoma of bone.","volume":"71","author":"Shih","year":"1995","journal-title":"Br J Cancer."},{"key":"2019111822461108000_B4","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1200\/JCO.1987.5.11.1811","article-title":"Solitary plasmacytoma of bone: treatment, progression, and survival.","volume":"5","author":"Chak","year":"1987","journal-title":"J Clin Oncol."},{"key":"2019111822461108000_B5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0360-3016(89)90008-4","article-title":"Solitary plasmacytoma of bone: Mayo Clinic experience.","volume":"16","author":"Frassica","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2019111822461108000_B6","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/1097-0142(19920315)69:6<1513::AID-CNCR2820690633>3.0.CO;2-X","article-title":"Plasmacytoma. Treatment results and conversion to myeloma.","volume":"69","author":"Holland","year":"1992","journal-title":"Cancer."},{"key":"2019111822461108000_B7","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0360-3016(98)00186-2","article-title":"Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy.","volume":"41","author":"Liebross","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2019111822461108000_B8","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications.","volume":"285","author":"Folkman","year":"1971","journal-title":"N Engl J Med."},{"key":"2019111822461108000_B9","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJM199512283332608","article-title":"Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis.","volume":"333","author":"Folkman","year":"1995","journal-title":"N Engl J Med."},{"key":"2019111822461108000_B10","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/S0959-8049(96)00423-6","article-title":"New perspectives in clinical oncology from angiogenesis research.","volume":"32A","author":"Folkman","year":"1996","journal-title":"Eur J Cancer."},{"key":"2019111822461108000_B11","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V96.6.2240","article-title":"Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes.","volume":"96","author":"Aguayo","year":"2000","journal-title":"Blood."},{"key":"2019111822461108000_B12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.1994.tb08304.x","article-title":"Bone marrow angiogenesis and progression in multiple myeloma.","volume":"87","author":"Vacca","year":"1994","journal-title":"Br J Haematol."},{"key":"2019111822461108000_B13","first-page":"3111","article-title":"Prognostic value of bone marrow angiogenesis in multiple myeloma.","volume":"6","author":"Rajkumar","year":"2000","journal-title":"Clin Cancer Res."},{"key":"2019111822461108000_B14","first-page":"2210","article-title":"Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis.","volume":"8","author":"Rajkumar","year":"2002","journal-title":"Clin Cancer Res."},{"key":"2019111822461108000_B15","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1182\/blood.V96.10.3374.h8003374_3374_3380","article-title":"Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia.","volume":"96","author":"Mesa","year":"2000","journal-title":"Blood."},{"key":"2019111822461108000_B16","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s002770000236","article-title":"Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma.","volume":"79","author":"Sezer","year":"2000","journal-title":"Ann Hematol."},{"key":"2019111822461108000_B17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199101033240101","article-title":"Tumor angiogenesis and metastasis\u2014correlation in invasive breast carcinoma.","volume":"324","author":"Weidner","year":"1991","journal-title":"N Engl J Med."},{"key":"2019111822461108000_B18","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/sj.leu.2401336","article-title":"Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma.","volume":"13","author":"Rajkumar","year":"1999","journal-title":"Leukemia."},{"key":"2019111822461108000_B19","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/cncr.10366","article-title":"Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.","volume":"94","author":"Wilder","year":"2002","journal-title":"Cancer."},{"key":"2019111822461108000_B20","first-page":"728","article-title":"Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.","volume":"59","author":"Bellamy","year":"1999","journal-title":"Cancer Res."},{"key":"2019111822461108000_B21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1034\/j.1600-0609.2001.00348.x","article-title":"Serum levels of the angiogenic cytokines basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in multiple myeloma.","volume":"66","author":"Sezer","year":"2001","journal-title":"Eur J Haematol."},{"key":"2019111822461108000_B22","first-page":"303b","article-title":"Angiogenesis in myeloma: expression of basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and their receptors by neoplastic plasma cells[abstract].","volume":"94","author":"Rajkumar","year":"1999","journal-title":"Blood."},{"key":"2019111822461108000_B23","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1182\/blood.V95.8.2630","article-title":"Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma.","volume":"95","author":"Dankbar","year":"2000","journal-title":"Blood."},{"key":"2019111822461108000_B24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10428190210203","article-title":"Vascular endothelial growth factor (VEGF) expression in plasmacytoma.","volume":"43","author":"Paydas","year":"2002","journal-title":"Leuk Lymphoma."},{"key":"2019111822461108000_B25","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1182\/blood.V98.2.428","article-title":"Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration.","volume":"98","author":"Podar","year":"2001","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/5\/1715\/1260962\/h80503001715.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/101\/5\/1715\/1260962\/h80503001715.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T22:46:24Z","timestamp":1574117184000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/101\/5\/1715\/106568\/Prognostic-value-of-angiogenesis-in-solitary-bone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,1]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,3,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-08-2441","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3,1]]}}}